How IPO-bound Gland Pharma’s valuation spiked under China’s Fosun

China’s Shanghai Fosun Pharmaceutical Group, which acquired a majority stake in Gland Pharma Ltd less than three years ago, will sell about a fifth of its stake in the drugmaker through its proposed initial public offering. Gland Pharma has filed its draft prospectus with the Securities and Exchange Board of India ......